Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE
Sign Up
Log in

Reliq Health Technologies Inc
F:MHN2

Watchlist Manager
Reliq Health Technologies Inc Logo
Reliq Health Technologies Inc
F:MHN2
Watchlist
Price: 0.1316 EUR Market Closed
Market Cap: €29m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall St Price Targets

MHN2 Price Targets Summary
Reliq Health Technologies Inc

There are no price targets for MHN2.
MHN2 Lowest Forecast
Not Available
MHN2 Average Forecast
Not Available
MHN2 Highest Forecast
Not Available
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Reliq Health Technologies Inc Competitors:
Price Targets
4917
Mandom Corp
-35% Downside
T
TFM
Thai Union Feedmill PCL
16% Upside
CIM
Chimera Investment Corp
12% Upside
4917
Mandom Corp
-35% Downside
T
TFM
Thai Union Feedmill PCL
16% Upside
CIM
Chimera Investment Corp
12% Upside

Revenue
Forecast

59% / Year
Past Growth
127% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
59% / Year
Past Growth
127% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 3 years is 127%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

See Also

Summary
MHN2 intrinsic value, competitors valuation, and company profile.
DCF Valuation
MHN2 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MHN2 stock valuation using valuation multiples.
Wall St Estimates
MHN2 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MHN2 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Reliq Health Technologies Inc listings:
OTC • USD
RQHTF
 XTSX • CAD
RHT
 SWB • EUR
MHN2
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MHN2's stock price target?
Not Available

MHN2 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Reliq Health Technologies Inc?
Projected CAGR
127%

Over the last 6 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 3 years is 127%.

Back to Top
ALPHA SPREAD
Follow us
Join 335,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett